BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37696249)

  • 1. The Impact of Long-Term Conditions and Comorbidity Patterns on COVID-19 Infection and Hospitalisation: A Cohort Study.
    Huang YT; Steptoe A; Patel RS; Fuller Thomson E; Cadar D
    Gerontology; 2023; 69(10):1200-1210. PubMed ID: 37696249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of long-term conditions and comorbidity patterns on COVID-19 infection and hospitalisation: a cohort study.
    Huang YT; Steptoe A; Patel RS; Thomson EF; Cadar D
    medRxiv; 2023 Apr; ():. PubMed ID: 37162831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
    Ge E; Li Y; Wu S; Candido E; Wei X
    PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
    Hasseli R; Mueller-Ladner U; Hoyer BF; Krause A; Lorenz HM; Pfeil A; Richter J; Schäfer M; Schmeiser T; Strangfeld A; Schulze-Koops H; Voll RE; Specker C; Regierer AC
    RMD Open; 2021 Jan; 7(1):. PubMed ID: 33479021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do dietary patterns in older age influence the development of cancer and cardiovascular disease: A longitudinal study of ageing.
    Nobbs HM; Yaxley A; Thomas J; Delaney C; Koczwara B; Luszcz M; Miller M
    Clin Nutr; 2016 Apr; 35(2):528-535. PubMed ID: 25912186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
    Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
    Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, demographical characteristics and hospitalisation of 3,010 patients with Covid-19 in Friuli Venezia Giulia Region (Northern Italy). A multivariate, population-based, statistical analysis.
    Gobbato M; Clagnan E; Burba I; Rizzi L; Grassetti L; Del Zotto S; Dal Maso L; Serraino D; Tonutti G
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):226-234. PubMed ID: 33412814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying pre-existing conditions and multimorbidity patterns associated with in-hospital mortality in patients with COVID-19.
    Bucholc M; Bradley D; Bennett D; Patterson L; Spiers R; Gibson D; Van Woerden H; Bjourson AJ
    Sci Rep; 2022 Oct; 12(1):17313. PubMed ID: 36243878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Comorbidities on the Infection Rate and Severity of COVID-19: Nationwide Cohort Study With Propensity Score Matching.
    Kim J; Park SH; Kim JM
    JMIR Public Health Surveill; 2022 Nov; 8(11):e35025. PubMed ID: 36265125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of comorbidity in community-dwelling older people hospitalised for fall-related injury: a cluster analysis.
    Vu T; Finch CF; Day L
    BMC Geriatr; 2011 Aug; 11():45. PubMed ID: 21851627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced age, comorbidity and the risk of mortality in COVID-19 infection.
    Endeshaw Y; Campbell K
    J Natl Med Assoc; 2022 Oct; 114(5):512-517. PubMed ID: 35786506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data.
    Zghebi SS; Steinke DT; Rutter MK; Ashcroft DM
    BMJ Open; 2020 Jul; 10(7):e033866. PubMed ID: 32611677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
    Drake TM; Riad AM; Fairfield CJ; Egan C; Knight SR; Pius R; Hardwick HE; Norman L; Shaw CA; McLean KA; Thompson AAR; Ho A; Swann OV; Sullivan M; Soares F; Holden KA; Merson L; Plotkin D; Sigfrid L; de Silva TI; Girvan M; Jackson C; Russell CD; Dunning J; Solomon T; Carson G; Olliaro P; Nguyen-Van-Tam JS; Turtle L; Docherty AB; Openshaw PJ; Baillie JK; Harrison EM; Semple MG;
    Lancet; 2021 Jul; 398(10296):223-237. PubMed ID: 34274064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System.
    Gu T; Mack JA; Salvatore M; Prabhu Sankar S; Valley TS; Singh K; Nallamothu BK; Kheterpal S; Lisabeth L; Fritsche LG; Mukherjee B
    JAMA Netw Open; 2020 Oct; 3(10):e2025197. PubMed ID: 33084902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Shrotri M; Krutikov M; Nacer-Laidi H; Azmi B; Palmer T; Giddings R; Fuller C; Irwin-Singer A; Baynton V; Tut G; Moss P; Hayward A; Copas A; Shallcross L
    Lancet Healthy Longev; 2022 Jul; 3(7):e470-e480. PubMed ID: 35813279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with multiple sclerosis: COVID-19 related disease activity and hospitalisations based on a nationwide cohort study.
    Andersen ML; Zegers FD; Jølving LR; Knudsen T; Stenager E; Nørgård BM
    Mult Scler Relat Disord; 2023 Nov; 79():105031. PubMed ID: 37778157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
    Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study.
    Bager P; Wohlfahrt J; Fonager J; Rasmussen M; Albertsen M; Michaelsen TY; Møller CH; Ethelberg S; Legarth R; Button MSF; Gubbels S; Voldstedlund M; Mølbak K; Skov RL; Fomsgaard A; Krause TG;
    Lancet Infect Dis; 2021 Nov; 21(11):1507-1517. PubMed ID: 34171231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Exposure to AIR Pollution and COVID-19 Mortality and Morbidity in DENmark: Who Is Most Susceptible? (AIRCODEN).
    Andersen ZJ; Zhang J; Lim YH; So R; Jørgensen JT; Mortensen LH; Napolitano GM; Cole-Hunter T; Loft S; Bhatt S; Hoek G; Brunekreef B; Westendorp R; Ketzel M; Brandt J; Lange T; Kølsen-Fisher T
    Res Rep Health Eff Inst; 2023 Nov; (214):1-41. PubMed ID: 38286761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.